Pharma Capital
CompanyCurrent (p)Volume
Gunsynd (GUN) 0.04 49,089,618
Sarossa (SARS) 1.52 14,021,775
GlaxoSmithKline (GSK) 1677.00 7,357,346
Oxford Biomedica (OXB) 4.71 2,638,016
Shire (SHP) 4734.50 2,548,531
GW Pharmaceuticals (GWP) 735.00 2,319,262
AstraZeneca (AZN) 4960.00 2,070,196
Vectura (VEC) 157.60 1,986,955
Indivior (INDV) 318.00 1,796,480
Amryt Pharma (AMYT) 21.25 1,532,542
ReNeuron Group (RENE) 2.35 1,262,451
Sareum Holdings (SAR) 0.93 1,227,796
Quantum Pharma (QP.) 40.50 990,000
Hikma Pharmaceuticals (HIK) 2000.00 951,011
Futura Medical (FUM) 49.75 682,697
BTG (BTG) 580.00 556,990
Abcam (ABC) 821.00 556,600
SkyePharma (SKP) 443.00 524,876
ValiRx (VAL) 2.50 493,441
Allergy Therapeutics (AGY) 24.00 473,533
Alliance Pharma (APH) 47.75 425,562
Motif Bio (MTFB) 24.75 380,021
Proteome Sciences (PRM) 4.18 350,920
Clinigen Group (CLIN) 770.00 331,919
Oxford Pharmascience Group (OXP) 2.85 327,016
Eden Research (EDEN) 10.75 295,880
OptiBiotix Health (OPTI) 80.00 262,526
Horizon Discovery Group (HZD) 162.50 258,826
Premaitha Health (NIPT) 10.63 252,640
Vernalis (VER) 25.13 221,635

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.